← Back to Clinical Trials
Recruiting NCT06723730

NCT06723730 ADDITIONAL EFFECTS OF MOBILIZATION WITH MOVEMENT WITH UPPER QUADRANT CORE STRENGTHENING IN ROTATOR CUFF RELATED PAIN:A RANDOMIZED CONTROLLED TRAIL

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06723730
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Rotator Cuff Syndrome
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-07-18
Primary Completion 2025-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Upper Quadrant Core Strengthening protocolMobilization with movement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a randomised control trial and the purpose of this study is to determine the additional effects of mobilization with movement with upper quadrant core strengthening in rotator cuff related pain .

Eligibility Criteria

Inclusion Criteria: * Age 18-65 years * Both genders * Unilateral shoulder pain of traumatic origin * Scoring should be less than 8 on numeric pain rating scale * Symptoms lasting more than 6 weeks * Pain on active shoulder movement * Pain provoked by atleast three of the following tests. A. Neer test B. Hawkins-Kennedy test C. Empty Can test D. Full Can test E. Painfull Arc test F. Resisted external rotation test * Patients reffered by a rehabilitation and orthopedic specialistwith diagnosis of rotator cuff injury, subacromial impingement syndrome, subacromial pain Exclusion Criteria: * History and Clinical presentation compatible with complete rotator cuff or bicep brachia rupture * Adhesive capsulitis * History of dislocation * Glenohumeral osteoarthritis * Cancer * Auto-immune inflammatory conditions and infection * Positive joint integrity tests ( Ant. and Post. Drawer tests) * Hill sachs lesions * Bankarts lesions * Cervical rib * Previous shoulder or neck surgery or fracture * Familiar pain provoked by neck movements * Presence of radicular sign * Diagnosis of fibromyalgia * Clinical depression * Rheumatoid arthritis * Poor bone quality ( osteoporosis) * Vertobrobasilar insufficiency test

Contact & Investigator

Central Contact

Raima Liaqat, MS-MSKPT*

✉ raimarana@gmail.com

📞 0302-9670275

Frequently Asked Questions

Who can join the NCT06723730 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06723730 currently recruiting?

Yes, NCT06723730 is actively recruiting participants. Contact the research team at raimarana@gmail.com for enrollment information.

Where is the NCT06723730 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06723730 clinical trial?

NCT06723730 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology